Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19109574 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for ANCA-Associated Vasculitides
Condition: Systemic Wegener's Granulomatosis
Interventions: Drug: Azathioprine: 2 mg/kg/day;   Drug: methotrexate 0.3 mg/kg/week, to a maximum and optimal dose of 25 mg/week

Study has passed its completion date and status has not been verified in more than two years.